На главную
Результаты поиска “Pharmaceutical cost control generic drugs”
Why Prescription Drugs Cost So Much | Michael Rea | TEDxKC
 
08:15
Would you be mad if you found out you were paying as much as 2000% more than your neighbor for a prescription? Furious, Michael Rea left his job as a pharmacist eight years ago to pursue a solution to the runaway cost of prescription drugs. Dr. Michael Rea founded Rx Savings Solutions in 2008 after routinely witnessing consumers struggling to pay for their medications. He noticed quickly at that time that consumers were paying much more than they needed to, which was attributable to a lack of information available to them. He set out on his mission to arm consumers with this information and add efficiency and transparency back into the world of pharmacy. Dr. Rea has been involved with research surrounding pharmacy transparency for over 10 years. He received his Doctor of Pharmacy degree from Creighton University. This talk was given at a TEDx event using the TED conference format but independently organized by a local community. Learn more at http://ted.com/tedx
Просмотров: 25517 TEDx Talks
Why a patient paid a $285 copay for a $40 drug
 
11:09
Americans pay more for prescription drugs than any country in the world, and the pharmaceutical industry earns billions in profits each year. Critics blame pharmacy benefit managers, or PBMs, for a portion of those high costs through their role as middlemen between insurance plans, drug makers and pharmacies—but PBMs say they save consumers money. NewsHour Weekend Megan Thompson reports.
Просмотров: 21521 PBS NewsHour
Conversation about drug pricing | Health care system | Heatlh & Medicine | Khan Academy
 
13:33
Dr. Laurence Baker talks to Sal about how drug prices are set. Created by Sal Khan. Watch the next lesson: https://www.khanacademy.org/science/health-and-medicine/health-care-system/v/health-care-costs-in-us-vs-europe?utm_source=YT&utm_medium=Desc&utm_campaign=healthandmedicine Missed the previous lesson? https://www.khanacademy.org/science/health-and-medicine/health-care-system/v/blue-cross-and-blue-shield?utm_source=YT&utm_medium=Desc&utm_campaign=healthandmedicine Health & Medicine on Khan Academy: No organ quite symbolizes love like the heart. One reason may be that your heart helps you live, by moving ~5 liters (1.3 gallons) of blood through almost 100,000 kilometers (62,000 miles) of blood vessels every single minute! It has to do this all day, everyday, without ever taking a vacation! Now that is true love. Learn about how the heart works, how blood flows through the heart, where the blood goes after it leaves the heart, and what your heart is doing when it makes the sound “Lub Dub.” About Khan Academy: Khan Academy is a nonprofit with a mission to provide a free, world-class education for anyone, anywhere. We believe learners of all ages should have unlimited access to free educational content they can master at their own pace. We use intelligent software, deep data analytics and intuitive user interfaces to help students and teachers around the world. Our resources cover preschool through early college education, including math, biology, chemistry, physics, economics, finance, history, grammar and more. We offer free personalized SAT test prep in partnership with the test developer, the College Board. Khan Academy has been translated into dozens of languages, and 100 million people use our platform worldwide every year. For more information, visit www.khanacademy.org, join us on Facebook or follow us on Twitter at @khanacademy. And remember, you can learn anything. For free. For everyone. Forever. #YouCanLearnAnything Subscribe to Khan Academy’s Health & Medicine channel: https://www.youtube.com/channel/UC1RAowgA3q8Gl7exSWJuDEw?sub_confirmation=1 Subscribe to Khan Academy: https://www.youtube.com/subscription_center?add_user=khanacademy
Просмотров: 55030 Khan Academy
Why Are Prescription Drugs So Expensive?
 
03:45
» Subscribe to NowThis World: http://go.nowth.is/World_Subscribe The First Amendment protects free speech, but there are some exceptions. How annoying can you be before it becomes illegal? Learn More: There's Actually Free Speech Zones http://www.cnn.com/2012/09/02/politics/rnc-protest-vermin-supreme/index.html?iref=allsearch First Amendment: An Overview http://www.law.cornell.edu/wex/first_amendment "The First Amendment of the United States Constitution protects the right to freedom of religion and freedom of expression from government interference." Who is the Reasonable Person? http://www.lclark.edu/live/files/7230-lcb144art1moranpdf "As the common law's most enduring fiction, the reasonable person fulfills a great many different roles across very different bodies of law." Harassment http://definitions.uslegal.com/h/harassment/ "Harassment is governed by state laws, which vary by state, but is generally defined as a course of conduct which annoys, threatens, intimidates, alarms, or puts a person in fear of their safety." Reasonable Person http://definitions.uslegal.com/r/reasonable-prudent-man/ "Reasonable or Prudent man is a hypothetical person used as a legal standard especially to determine whether someone acted with negligence." Watch More: Is Online Trolling Illegal? https://www.youtube.com/watch?v=vdVJ2L8SabU _________________________ NowThis World is dedicated to bringing you topical explainers about the world around you. Each week we’ll be exploring current stories in international news, by examining the facts, providing historical context, and outlining the key players involved. We’ll also highlight powerful countries, ideologies, influential leaders, and ongoing global conflicts that are shaping the current landscape of the international community across the globe today. More from NowThis: » Subscribe to NowThis News: http://go.nowth.is/News_Subscribe » Like NowThis World on Facebook: https://go.nowth.is/World_Facebook » Connect with Judah: Follow @judah_robinson on Twitter – Facebook: http://go.nowth.is/LikeJudah » Connect with Versha: Follow @versharma on Twitter – Facebook: http://go.nowth.is/LikeVersha http://www.youtube.com/nowthisworld
Просмотров: 109381 NowThis World
How Trump plans to lower drug prices in US
 
08:22
Dr. Janette Nesheiwat and Heritage Foundation senior fellow Ed Haislmaier discuss why European countries are paying less for prescription drugs than the United States and how the Trump administration plans to combat this problem.
Просмотров: 5202 Fox Business
Drug Costs & Generics
 
07:59
How we can control drug cost
Просмотров: 122 drmdk
Making Drugs Cheaper Without Stifling Innovation -- Euro Style
 
05:44
Can we keep drug prices low without hurting innovation? Well, drugs are a lot cheaper in Europe than in the US, and there's still plenty of innovation over there. So what's going on? It's called reference pricing, and it's pretty much genius. Those of you who want to read more can go here: http://theincidentaleconomist.com/wordpress/?p=72475 John Green -- Executive Producer Stan Muller -- Director, Producer Aaron Carroll -- Writer Mark Olsen -- Graphics http://www.twitter.com/aaronecarroll http://www.twitter.com/crashcoursestan http://www.twitter.com/johngreen http://www.twitter.com/olsenvideo And the housekeeping: 1) You can support Healthcare Triage on Patreon: http://vid.io/xqXr Every little bit helps make the show better! 2) Check out our Facebook page: http://goo.gl/LnOq5z 3) We still have merchandise available at http://www.hctmerch.com
Просмотров: 41243 Healthcare Triage
Changing the drug pricing game
 
14:26
Americans pay more for prescription drugs than people in most other Western countries. And unfortunately, high drug costs mean low accessibility for many of those in need of life-saving medications. Peter Bach envisions a different approach to pharmaceutical pricing. As Director of Memorial Sloan Kettering Hospital’s Center for Health Policy and Outcomes and the founder of the Drug Pricing Lab, Peter and his team strive to identify more rational approaches to drug pricing and to bring transparency to the process. Tune in to Peter’s 2017 TEDMED Talk to learn how he is working to balance getting patients the critical treatments they need, while also ensuring drug developers have adequate funding to research, improve, and develop important therapeutics.
Просмотров: 4079 TEDMED
Generic Drugs: Learn about the Lifecycle from Brand Name Prescriptions to Generics
 
02:37
Ever wonder why generic drugs cost $4 at some pharmacies? Generic drugs are the final stage in a long lifecycle that starts with innovator biopharmaceutical research companies researching and developing brand prescription medicines. This video highlights the stops & starts, successes & failures that often result in low-cost options for many people. Keep in mind as you watch that only 2 out of 10 drugs approved by the FDA will ever earn revenues that exceed average R&D costs. Help others understand the story behind the prescription drug lifecycle by sharing this video.
Просмотров: 48609 PhRMAPress
Medications Keep Getting More Expensive | Professor Speaks | Pro Pharma
 
16:13
Professor Speaks: Episode 76 - Generic Drug Pricing Topics Discussed: Generic prices are increasing 1. What are generic drugs? 2. Why have prices increased? a. Consolidation of the market b. Many manufacturers bought out so prices increased with decreased demand c. Manufacturing gaps (PhRMA stopped making due to quality problems) d. Current price hikes of 20-85% on some generics 3. Who controls price? a. Manufacturers b. Middlemen – PBMs, wholesalers, repackagers c. MAC lists – Plans and PBMs 4. Price vs. Affordability 5. What to do? Resources: https://www.goodrx.com Make sure to click that subscribe button and click the bell icon to receive notifications when we post new videos. To lean more about Pro Pharma visit: http://www.propharmaconsultants.com
Просмотров: 277 Pro Pharma Education
A07 Pharma Pricing Control
 
06:06
Pharmaceutical Pricing Controls. This will be the beginning of getting Prescription drug costs under control.
Просмотров: 6 CS2News
Generics—Anything But Generic! Understanding the Unknowns and Pricing of Generic Drugs
 
01:00:27
Join this informative one-hour webinar to learn about generic drugs and generic drug pricing. Hear strategies you can implement to ensure you are receiving the best generic rate possible for your plan. Gain an understanding of a MAC list, the qualifications generic drugs must meet to be on a MAC list, and how MAC and non-MAC pricing affect your overall costs. Learn about other generic drug topics such as the role of biosimilars, specialty generics, preferred/non-preferred generic copay strategies and managing generic drug shortages. Leave this session armed with information to proactively limit generic drug cost increases while implementing plan design changes that increase the utilization of generic drugs.
Pharmaceutical Supply Chain Managment
 
19:53
Scott Hebert, Vice President of Sterling Simulations worked with one of the largest global pharmaceutical companies to rework their supply chain for a recently patented generic drug.
Просмотров: 1569 AnyLogic
Cost Of Prescription Drugs Still Skyrocketing
 
02:20
Here’s some tips on how to save!
Просмотров: 65 CBSDFW
Drug pricing controls detrimental: Kiran Mazumdar-Shaw
 
07:42
Kiran Mazumdar-Shaw, CMD of Biocon, tells NDTV that the NPPA's decision to add more drugs under price control will have a detrimental impact on the industry and the pharmaceutical sector has been completely overlooked in this Budget. Watch more videos: http://www.ndtv.com/video
Просмотров: 1057 NDTV
New FDA chief wants to bring prescription costs down
 
02:15
Dr. Gottlieb wants to shorten the production time of drugs to lower the cost of them; Dr. Marc Siegel reports for 'Special Report'
Просмотров: 1081 Fox News
The Pharmaceutical Industry
 
00:56
We are dependent on the pharmaceutical industry to save lives, so costs must come down. Pharmaceuticals Bill Novelli: The pharmaceutical industry has an important role to play in American health. First of all, this is a lifesaving industry. This is the industry that we hope is going to be able to control Alzheimer's and Parkinson's and these other diseases of . . . of the elderly. So we are dependent upon the pharmaceutical industry. But at the same time, prescription drugs cost too much in this country, and we have to really move to generics. We have to get costs so that they're affordable for people. We have to figure out a way so that the pharmaceutical companies can make a reasonable profit, and people can afford their drugs. And right now we're not there. Recorded on: 9/27/07 Pharmaceuticals Bill Novelli: The pharmaceutical industry has an important role to play in American health. First of all, this is a lifesaving industry. This is the industry that we hope is going to be able to control Alzheimer's and Parkinson's and these other diseases of . . . of the elderly. So we are dependent upon the pharmaceutical industry. But at the same time, prescription drugs cost too much in this country, and we have to really move to generics. We have to get costs so that they're affordable for people. We have to figure out a way so that the pharmaceutical companies can make a reasonable profit, and people can afford their drugs. And right now we're not there. Recorded on: 9/27/07
Просмотров: 350 Big Think
Skyrocketing Drug Prices: A Bitter Pill to Swallow
 
46:24
While new discoveries in medicine have fueled the drug development industry, our ability to control costs and broaden access to drugs has decreased. What is the role of academic medical centers to control such costs? How can our basic science knowledge and impact on healthcare policy contribute to lowering drug costs? Moderated by Carolyn Johnson, The Washington Post reporter who covers the intersection between business and health. Panelists: Jeremy Greene, M.A., M.D., Ph.D. and Redonda Miller, M.B.A., M.D. #JHMBootCamp View more from the 2018 Science Writers' Boot Camp at: https://www.hopkinsmedicine.org/institute_basic_biomedical_sciences/news_events/2018_The_Price_We_Pay.html
Просмотров: 157 Johns Hopkins Medicine
Controlling Drug Costs
 
03:11
Learn more at our website: https://goo.gl/pB2XsA In this video, Ezekiel J. Emanuel talks about some methods for controlling drug costs, including re-importation from Canada, and allowing Medicare to negotiate drug prices. He recommends value-based pricing as a strategy. And he suggests that sometime in the next decade, one way or another, we will see serious legislation regulating pharmaceutical pricing.
Просмотров: 122 Penn Medical Ethics & Health Policy Online
The Future Of Generics
 
03:31
Mylan President, Heather Bresch, says the generic drug market will continue to be a winner.
Просмотров: 2458 Forbes
Big Pharma Greed: Your Generic Drugs Are Getting More Expensive - The Ring Of Fire
 
09:54
The pharmaceutical industry holds enormous power over our health, our politicians, and even our economy. With their products being a necessity for a large part of the population, they have the ability to charge exorbitant amounts of money for their products, with the only relief for consumers coming in the form of generics. But today, that relief is disappearing. Ring of Fire’s Farron Cousins and attorney Stephen Burg discuss how this is happening. Follow more of our stories at http://www.RingofFireRadio.com Spread the word! LIKE and SHARE this video or leave a comment to help direct attention to the stories that matter. And SUBSCRIBE to stay connected with Ring of Fire's video content! Listen to Ring of Fire on Saturdays from 3pm - 6pm Eastern! Listen live via the Progressive Voices Channel on TuneIn: http://tunein.com/radio/Progressive-Voices-s189055/ Or find a station here: http://www.ringoffireradio.com/station/ Watch Ring of Fire every weekday at 8:30pm EST on Free Speech TV! Support Ring of Fire by subscribing to our YouTube channel: http://www.youtube.com/user/golefttv You can also support us here: http://www.ringoffireradio.com/support/ Your continued support keeps Ring of Fire on the air! Be sociable! Follow us on: Facebook: http://www.facebook.com/RingofFireRadio Twitter: http://www.twitter.com/RingofFireRadio Google+: http://plus.google.com/118415831573195648557 Support us further by shopping on Amazon via our Amazon-Ring of Fire partnership link. A portion of the sales will come back to Ring of Fire at no extra cost to you. Bookmark and follow the link below and continue shopping as usual! Amazon - Ring of Fire partnership link: http://www.amazon.com/?tag=rinoffir-20
Просмотров: 9860 The Ring of Fire
Pharma Price Gouging Out of Control - The Ring Of Fire
 
11:33
Last week, Martin Shkreli managed to make the entire United States angry by buying the rights to a generic drug and then raising the price by over 5,000% overnight. What Shkreli did is deplorable, but he didn’t invent that scheme – that’s how Big Pharma has been operating for decades. For more on this, let’s check in with Howard Nations.… Follow more of our stories at http://www.RingofFireRadio.com Spread the word! LIKE and SHARE this video or leave a comment to help direct attention to the stories that matter. And SUBSCRIBE to stay connected with Ring of Fire's video content! Listen to Ring of Fire on Saturdays from 3pm - 6pm Eastern! Listen live via the Progressive Voices Channel on TuneIn: http://tunein.com/radio/Progressive-Voices-s189055/ Or find a station here: http://www.ringoffireradio.com/station/ Watch Ring of Fire every weekday at 8:30pm EST on Free Speech TV! Support Ring of Fire by subscribing to our YouTube channel: http://www.youtube.com/user/golefttv You can also support us here: http://www.ringoffireradio.com/support/ Your continued support keeps Ring of Fire on the air! Be sociable! Follow us on: Facebook: http://www.facebook.com/RingofFireRadio Twitter: http://www.twitter.com/RingofFireRadio Google+: http://plus.google.com/118415831573195648557 Support us further by shopping on Amazon via our Amazon-Ring of Fire partnership link. A portion of the sales will come back to Ring of Fire at no extra cost to you. Bookmark and follow the link below and continue shopping as usual! Amazon - Ring of Fire partnership link: http://www.amazon.com/?tag=rinoffir-20
Просмотров: 1143 The Ring of Fire
Ask UNMC: Cost benefit of generic drugs
 
01:04
Why do generic prescription drugs cost less than brand name products? Charles Krobot, Pharm.D. College of Pharmacy Pharmacy Practice University of Nebraska Medical Center
Просмотров: 259 UNMCEDU
Generic drug prices on the rise
 
02:19
How to save money on prescriptions.
Просмотров: 57 WCPO.com | 9 On Your Side
Sarokaar - Withdrawal of NPPA’s guidelines on Drug Price Control
 
57:12
In a recent decision, the National Pharmaceutical Pricing Authority (NPPA) has withdrawn its guidelines for price control on drugs which do not fall under the National List of Essential Medicines (NLEM). This move is said to have an impact on 108 non-essential drugs. These guidelines were earlier issued under its Drug Prices Control Order which empowered NPPA to control prices of drugs not falling under NLEM also. Many are concerned that this might lead to a steep price rise of certain drugs in India, some of which are required in treatment of serious medical conditions, as the pharma companies would be now free to fix their prices on these drugs. Watch Sarokaar with eminent panellists discussing the issue from various perspectives. Guests: Dr. Sambit Patra (National Spokesperson, BJP) ; Amitabh Guha (National Convener, Jan Swasthya Abhiyan ) ; M L Sharma (Advocate and Petitioner​) ; D G Shah (Secretary General, Indian Pharmaceutical Alliance) ; Dr. Vikas Vajpayee (Assistant Professor, Centre for Social Medicine and Community Health, JNU) Anchor: Amrita Rai
Просмотров: 5355 Rajya Sabha TV
Comparing prescription drug prices
 
02:07
Comparing prescription drug prices from pharmacies in your neighborhood.
Просмотров: 1096 ABC Action News
New website helps find prescription drug costs in your area
 
02:14
http://www.ctvvancouverisland.ca http://www.facebook.com/ctvvi QUALICUM BEACH - The cost of prescription drugs can be a source of pain, but a new website is working to take the hurt out of buying prescription pills. A website launched today called pharmacycompass.ca is designed to arm consumers with the most up-to-date prices for their medication and where to get them the cheapest. The site asks what type of prescription you are looking for and where you live. It then breaks down the cost of your drugs at local pharmacies. In Canada's oldest municipality, news of the website is being met with excitement and scepticism. A local pharmacist says while "pharmacycompass.ca" will offer consumers a quick look at where to buy cheap drugs, it won't point them in the direction of a competent and knowledgeable professional behind the counter. Follow Scott Cunningham on Twitter: http://www.twitter.com/CTVNewsScott
Просмотров: 240 ctvvi
The High Cost of Prescription Drugs in the United States
 
03:35
This Special Communication presents evidence on elevated prescription drug prices in the US and suggests strategies to enhance pricing competition and generate evidence about cost-effective alternatives. Read the article at: http://ja.ma/2b6WPlI.
Просмотров: 1235 JAMA
Part D Drug Plan -  How Formularies & Tiers Can Cost You!!
 
06:18
http://www.FirstMedicareAdvisors.com - - Recorded Hotline: 1-800-958-8171 - Office: 1-800-825-2919. - - Email: info@firstmedicareadvisors.com - - PS: No Sales Pitches Ever! We hate'em as much as you do! The Medicare Part D is your drug coverage. Here is a key point: The Part D drug plan is completely different than the drug plan you may have had as an individual or at your workplace. They are not the same types of benefit. Part D Plans are required to cover certain types of drugs, but they may choose which drugs it covers. Your drug plans are offered by private insurance companies. Before we talk about drug tiers, let’s talk about how the companies offer their benefits: All prescription drug plans have a formulary that lists the drugs covered. By law, both brand name and generic drugs must be included in the formulary. They also must have a variety of those categories. Each plan’s formulary can be different from other company benefits. And formularies can change from one year to the next. Well, how does the drug plan create its formulary? The purpose of the formulary is to identify drugs that work for you. But - also price-effective for the company. The effort to control costs is why they use of drug tiers The companies divide the drugs they provide into “tiers.” The level each drug goes into is based on what price the plan pays to the pharmaceutical manufacturer. If a drug program receives a lower price on a drug, then it can place it in a lower tier and pass the savings onto you. Each plan has a different copay, coinsurance, and deductible. Therefore, you pay more for a drug on one plan’s formulary over another plan. Each insurance company decides its own tier formula. They may offer you a formulary with several different levels. The lower level drugs have the lower cost. The price increases based on the higher tier. If you have a question or need help with your different parts of Medicare give us a call at either our Recorded Hotline at 1-800-958-8171 and record your question or request. The second and quickest way is to call my office direct at 1-800-825-2919. You’ll get an answer to point you in the right direction. Here’s how drug tiers typically work: Tier 1 is usually generic drugs with lower costs. Tier 2 is usually “a preferred” brand name medication. These are drugs that the insurance company has negotiated to get lower prices. Tier 3 is called the “non-preferred” drug brands that are the same as the tier 2 brand names. But the plan must charge the drug company price. Tier 4 is usually the specialty drugs. You will often be required to pay a coinsurance and copay on these drugs. Tier 5 is usually the experimental drugs and cost the most. Most likely your formulary is going to change. Why? Because tiers will be changing for different drugs? For example, a few years back I was taking a drug called Lipitor. Man, was it pricey! But eventually, a generic called Atorvastatin came on the market. Fortunately - the price dropped dramatically. Regularly generic versions of drugs come into the market. The pricing for drugs may be renegotiated during the year. Both these scenarios can cause your plan to add or remove your drug from your formulary. The plan may move it to another tier. To save money you want to know and understand your plan’s drug tiers. When you enroll in a Part D plan check the tiers for the drugs, you currently take. Then you can calculate your copay or coinsurance. If you’re prescribed a new drug by your doctor, find it in your formulary and see which tier it is in. What happens if your doctor prescribes a drug that costs more because of a higher tier in your formulary? If that happens, ask your doctor to prescribe a drug that costs less on a lower tier. Generally, generics are a good place to look for prescription savings. Talk to your doctor about what lower-priced drugs may work for you. If you can’t find a good similar drug file a request and ask your plan to allow you to pay a lower price for a higher-level tier drug. If you need additional information about your prescription drug resources, give our office a call on our Recorded Hotline. That number is 1-800-958-8171 and then record your question or request. However, the best way is to call my office direct at 1-800-825-2919. You’ll get an answer to point you in the right direction.
Просмотров: 288 Dale Stringer
Strategies to Control Specialty Drug Costs
 
58:44
Join Marybeth Gray of Trion for a one hour webinar focused on controlling the cost of specialty drugs. Learn about the various specialty drugs on the market and gain insight on the pharmacy landscape, including specialty drugs in the pipeline. Hear real strategies that you can implement to control the specialty drug spend for your plan.
The Real Deal: Generic drug prices
 
02:42
ALBANY -- If you take generic medications, you've likely noticed you're paying more for some of them. Certain drugs have quadrupled in price over the last year. Patients and pharmacists are furious and now lawmakers are looking to do something about it. "Last month, I had to order like 6 different prescriptions and it came to quite a bit," says Arlene Laboy of Sloansville. She recently received a warning from her pharmacist that she was not expecting, "they have told me that some of my medications are going to be increased," she says. Laboy, like millions of others, relies on a number of generic drugs to stay healthy and she's paying a lot more for a few of the same pills she's been taking for years. "It's a sporadic issue, it may be a handful of medications, maybe 15-20 at a time but what is incredible is the percentage of increase in price, something that could be 8 cents is now 9 dollars a pill," says John McDonald, owner of Marra's Pharmacy in Cohoes. A few examples, the price of Doxycycline, an antibiotic used to treat infections went from $20 for a 100-pill bottle in October of 2013 to nearly $2,000 a year later, Albuterol Sulfate, a common asthma treatment shot from $11 per bottle to $434. "There are different reasons, sometimes valid reasons‚there may be a raw material shortage, an FDA inspection may close down a few facilities usually in a foreign country and then there are times there are no valid excuses, we don't get a valid reason," McDonald says. Even if you're not taking any of the impacted medications, you're still paying for them, "we spend 15 cents of every premium dollar just on paying for drugs," says Paul Macielak, the President of the New York State Health Plan Association which represents insurers. And at the moment, he says, there is little oversight on how those prices are set, "pharmaceuticals today is the most profitable sector in healthcare, I mean I think the running profit is around 20%, overall that's more than five times what health plans and hospitals earn in terms of any kind of a margin, so that's something I think warrants somebody looking at," he says. Hearings are being held both on Capitol Hill and in Albany to discuss what can be done to increase transparency of generic drug pricing. "For the most part, generics are very cost effective options, the problem is though when you have these roller coaster episodes, it really wreaks havoc in the market," McDonald says. The Generic Pharmaceutical Association says while there have been some price spikes, they do not reflect the broader U.S. market, which includes 12,000 generic medications. Either way, for Laboy who is on a fixed income, these ups and downs are causing some serious budget issues.
Просмотров: 370 CBS6 Albany
Pharma Industry Displeased With Modi Government’s Move To Control Drug Pricing
 
02:16
The Government's recent move to cap the price of multiple drugs has led to a furore in the pharma sector, with Big Pharma leading from the front. ET NOW brings you this special report on why the industry is crying foul. -~-~~-~~~-~~-~- Must Watch: "PM Narendra Modi Backs Vijay Mallya Says Rahul Gandhi" → https://www.youtube.com/watch?v=Vlj1C4zEE44 -~-~~-~~~-~~-~-
Просмотров: 403 ET NOW
Inside the Indian Generic Drug Manufacturer Cipla
 
02:53
India produces over 30% of the world's entire supply of generic drugs. Cipla is one of India's largest drug manufacturers. It supplies antiretroviral drugs to about one third of AIDS patients under treatment in Africa. C&EN Senior Correspondent Jean-François Tremblay went inside Cipla's advanced pharmaceutical ingredient manufacturing plant to learn more about the stringent regulations it must follow. India's future as the world's drugstore is a controversial topic. Other drugmakers have been heavily fined, or had products recalled or banned, because of problems at plants. And India is under pressure to make its patent system more like those in western nations. But India has found a market for low-cost drugs and that market isn't about to disappear. More at http://cenm.ag/cpla Like C&EN? Want more chemistry video goodness? Subscribe to our YouTube channel: https://www.youtube.com/user/CENonline Subscribe to C&EN to watch science videos with a focus on chemistry, and to hear from the researchers behind it all. -- Looking for C&EN elsewhere on the internet? Homepage: http://cen.acs.org Facebook: http://www.facebook.com/CENews Twitter: http://www.twitter.com/cenmag Tumblr: http://cenwatchglass.tumblr.com
Просмотров: 83200 CEN Online
Medical Beneficiary and Pharmaceutical Services Division’s Drug Price Regulation
 
02:47
The Medical Beneficiary and Pharmaceutical Services Division (MBPSD) led the development and implementation of the Drug Price Regulation, part of the Pharmaceutical Services Act. As a result, the division lowered the cost of generic drug prices from 35% to 20% of brand price over the last 2 years resulting in a drug cost savings exceeding governments’ public commitment of $110 million. This frees up significant funds to sustain the drug budget; ensure government and citizens are paying the lowest prices across Canada and can access the medications they need for improved health outcomes – a key priority of the Ministry of Health. This initiative has been very complex; has required extensive analysis of the supply chain; stakeholder consultation; policy and legal expertise; on-going clinical expertise and oversight; and careful planning and on-going management of issues/risks that have been encountered across the supply chain to achieve our goal.
Просмотров: 290 BCPublicService
How to lower prescription drug costs
 
01:48
Do those prescription drug cards really save you money? Let Joe Know put it to the test.
Просмотров: 118 ABC15 Arizona
Cost of Medicines in Context
 
01:10
Prescription drug spending is making up only 9.5% of total healthcare cost. Learn more about what is behind the cost of medicines. http://igeahub.com/2017/04/08/cost-of-medicines-in-context
Просмотров: 327 IgeaHub
Affordable healthcare and Price Control Regime || upsc preparation
 
15:38
Balancing Affordability with Access The healthcare system in India is characterised by a rapaciously expanding private sector and prohibitive out-of-pocket (OOP) health expenditures that hinder access to healthcare, particularly for the poor and the vulnerable. Either they are simply unable to afford such high costs or are further impoverished by the burden of healthcare expenditures. More disconcerting in this scenario is the spiralling cost of therapeutics, which has emerged as a key driver of the increasing share of healthcare in household consumption expenditures over time. Almost two-fifths of the overall healthcare costs and more than half of the total private OOP healthcare costs in India are for therapeutics. In this context, recent initiatives of the central government for (essential) drug price control, such as the new Drug (Price Control) Order (DPCO) of 2013 or the proposed expansion of the generic drugs scheme by increasing the number of Jan Aushadhi Kendras, are welcome moves, indeed, but to what extent efficacious, is debatable. Pricing of medicines (essentials) has been an issue of concern even with the central governments that preceded the current one. But, other than repeated promises that were made from time to time by various central governments, nothing much has been done at the statutory level to ensure free medicines for the poor. What has been achieved till date are some state-specific initiatives, and some incentive offers made by the central government to the states through the National Health Mission for launching free drugs and diagnostic services. The policy overtone in this aspect is historically preponderated by “price control,” which, as of now, could encompass even less than a quarter of the domestic pharmaceuticals market. On the other hand, deficient supply chain management prevents the utilisation of low-cost generic drugs from picking up. Media reports on the crumbling status of the already existing Jan Aushadhi Kendras due to procurement delays and errant supplies are rampant. Poor forecasts, archaic procurement systems, and small markets, among other things, can cause supply bottlenecks; at the same time, demand is constrained by the lack of clarity on the quality of generic drugs. With the key parts of the drug regulatory systems in the country being controlled by the states, there are no consistent standards for enforcement. Given this, confounding estimates of counterfeit drugs are available. The pharmaceutical manufacturers estimate that 20% of all drugs sold in major city markets are substandard or counterfeit, while the government estimates that these account for almost 10% of the total pharmaceutical market in the country. To worsen matters, the commonly held perception that low-priced drugs are more likely to be spurious can hardly be contested. India’s universal health coverage framework is based on the tenets of equity, access, and affordability; and pursuing any of these goals would entail some inevitable societal trade-offs. Take the example of the insurance-based financing mechanism for universal health coverage proposed by the current government. While the programme may ensure access to healthcare for the poor, it may lack in safeguarding affordability. In the absence of commensurate supply-side strategies, such as strengthening the public sector provisioning of essential healthcare, the programme is likely to benefit the private players who already dominate healthcare provisioning in India. In such a situation, “price control” may contain the prices of essential drugs, but only when coupled with supply-side interventions such as enforcing a drug regulatory system, improving supply chain management, and understanding the pharmaceutical market. Otherwise, price control may distort access to affordable drugs. Striking the right balance between these goals is not only an economic decision, but also a matter of political will. It has been empirically proven that free or low-cost healthcare provisioning by the state remains the best way to enhance the health and well-being of households, provided infrastructural bottlenecks are addressed, and low-cost medicines and diagnostics made available to all. However, the current paradigm shift towards demand-side financing of healthcare is indicative of the fact that the government is striving to limit its role in facilitating access to healthcare, while leaving the provisioning to the private sector.
Просмотров: 21 UPSC Preparation
Drugmaker Pfizer plans to raise prices on 41 prescription drugs
 
08:38
Navigating the drug pricing maze can be very confusing and frustrating. Bob Herman, health care business reporter for Axios, joins CBSN to discuss his article on drug pricing in America. Subscribe to the CBS News Channel HERE: http://youtube.com/cbsnews Watch CBSN live HERE: http://cbsn.ws/1PlLpZ7 Follow CBS News on Instagram HERE: https://www.instagram.com/cbsnews/ Like CBS News on Facebook HERE: http://facebook.com/cbsnews Follow CBS News on Twitter HERE: http://twitter.com/cbsnews Get the latest news and best in original reporting from CBS News delivered to your inbox. Subscribe to newsletters HERE: http://cbsn.ws/1RqHw7T Get your news on the go! Download CBS News mobile apps HERE: http://cbsn.ws/1Xb1WC8 Get new episodes of shows you love across devices the next day, stream CBSN and local news live, and watch full seasons of CBS fan favorites like Star Trek Discovery anytime, anywhere with CBS All Access. Try it free! http://bit.ly/1OQA29B --- CBSN is the first digital streaming news network that will allow Internet-connected consumers to watch live, anchored news coverage on their connected TV and other devices. At launch, the network is available 24/7 and makes all of the resources of CBS News available directly on digital platforms with live, anchored coverage 15 hours each weekday. CBSN. Always On.
Просмотров: 8456 CBS News
HHS secretary on Medicare drug pricing, gender definitions
 
09:55
President Trump has announced several proposed changes to how Medicare buys certain expensive prescription drugs, relying in part upon a benchmark price index of other developed countries, who negotiate lower prices. But critics wonder why the U.S. government doesn't do the negotiating itself. William Brangham speaks to Secretary of Health and Human Services Alex Azar, who is overseeing the plan. Stream your PBS favorites with the PBS app: https://to.pbs.org/2Jb8twG Find more from PBS NewsHour at https://www.pbs.org/newshour Subscribe to our YouTube channel: https://bit.ly/2HfsCD6 Follow us: Facebook: http://www.pbs.org/newshour Twitter: http://www.twitter.com/newshour Instagram: http://www.instagram.com/newshour Snapchat: @pbsnews Subscribe: PBS NewsHour podcasts: https://www.pbs.org/newshour/podcasts Newsletters: https://www.pbs.org/newshour/subscribe
Просмотров: 2238 PBS NewsHour
Overpaying for Prescription Drugs: The Copay Clawback Phenomenon
 
02:21
Full study: http://bit.ly/overpaydrugs A short video on prescription drug overpayments (also known as “clawbacks”). Prescription drug overpayments occur when commercially insured patients’ copayments exceed the total cost of the drug to their insurer or pharmacy benefit manager. While the practice has been acknowledged and discussed in the media, it has never been quantified in large samples. We use pharmacy claims data from a large commercial insurer, combined with data on national average drug reimbursements, to identify claims that likely involved overpayments. In 2013, almost one quarter of filled pharmacy prescriptions (23%) involved a patient copayment that exceeded the average reimbursement paid by the insurer by more than $2.00. Among these overpayment claims, the average overpayment is $7.69. Overpayments are more likely on claims for generic versus brand drugs (28% vs. 6%), but the average size of the overpayment on generic claims is smaller ($7.32 vs. $13.46). In 2013, total overpayments amounted to $135 million in our sample, or $10.51 per covered life. With over 200 million Americans commercially insured in 2013, these findings suggest the practice of overpayments may account for a non-negligible share of overall drug spending and patient out-of-pocket costs. Authors: Karen Van Nuys, PhD Executive Director, value of life sciences innovation project, USC Schaeffer Center Geoffrey Joyce, PhD Director of Health Policy, USC Schaeffer Center Rocio Ribero, PhD Project Specialist, USC Schaeffer Center  Dana P. Goldman, PhD Leonard D. Schaeffer Director's Chair and Distinguished Professor of Public Policy, Pharmacy, and Economics, University of Southern California For more information about the USC Schaeffer Center please visit http://healthpolicy.usc.edu
Просмотров: 343 USC Price
Coverage on talking with Experts on Drug Prices Control Order- RajyaSabha Tv
 
23:21
Experts talking on Drug Prices Control Order- RajyaSabha Tv
How to Buy Prescription Drugs in Mexico without a Prescription
 
08:23
As a full time RVer, medical insurance and prescription management can be challenging. Recently I ran out of my migraine medicine so took a trip to Mexico to buy my meds over the counter. This video shows how to buy prescription drugs in Mexico and answers questions about what can and can NOT be bought. Watch and join me as I visit Mexico with my friend Bob to stock up on prescription medicine.
Просмотров: 146537 Carolyn's RV Life
Your Prescription Drugs Just Got More Expensive
 
07:43
Help us cover the political revolution: http://www.patreon.com/TYTNation "Pharmaceutical giant Pfizer raised prices on about 100 drugs this week, the second round of increases for the company this year. Overall, many of the drugs’ prices have increased by double-digit percentages this year, according to Ars Technica. The Financial Times first reported the price hike. Among the drugs who have seen price hikes are Viagra, the erectile dysfunction drug, and Norvasc blood pressure pills. The increased prices come amid heightened focus from lawmakers on drug prices." http://thehill.com/policy/healthcare/395483-pfizer-hikes-prices-on-dozens-of-drugs Shop at Amazon & support TYT Nation! http://ow.ly/LAKHU Like Our Facebook Page! http://www.Facebook.com/TYTNation Subscribe to our Network Partner: The Young Turks. http://www.youtube.com/theyoungturks http://www.tytnetwork.com
Просмотров: 1911 TYT Nation
Fighting skyrocketing prescription drug prices
 
03:46
By: James Tully HARRISBURG, Pa. -- Prescription drug spending is surging in the United States, with one report showing a 13 percent increase last year, the largest rise since the beginning of the century. Despite the rising costs, there are ways for consumers to help keep the drugs so many people need to stay healthy from draining bank accounts and becoming overwhelming. They're costs and struggles Lori Mardis, of Cumberland County, know all too well. Nine different medications in the morning and afternoon, all coming with a hefty price tag. There are the daily calls to the liver, heart or kidney specialist, an exhausting process, but none of it is for her. And it's all for her dad, and to Lori, there's no other option. "He would have to be in a home, or worse he could have passed away," she said. But Lori's process to becoming her father, Ed's, caregiver has been a struggle. "You can call the insurance company. You can ask the same question five times to a different person and you'll get a different answer, where do I go from there," Lori said. The rising cost of prescription drugs was the main issue. After Ed didn't meet the criteria to qualify for PACE or PACENet, two of Pennsylvania's biggest assistance programs, Lori didn't know where to turn. CBS 21 featured her struggles to find assistance programs in February. The company that manufactures the most expensive medication her father is prescribed saw our story and reached out to Lori. They had an assistance program. By going directly to the manufacturer she received a free year's supply, a nearly $8,000 value. State Sen. Pat Vance, chair of Pennsylvania's Health and Welfare Committee, said often times if you ask you'll find many manufacturers do have assistance programs. She also does feel that often times drug companies charge too much, but it's a two-way street. "They realize as soon as it goes off patent and becomes generic everybody else is going to make it too, they think they need to make the money upfront and there's something to be said for that," Vance said. But, what if that's not the root of the problem? "Now this is going to be a radical statement from a former nurse, but I'm not so sure that seniors don't take too much medication and one contradicts the other," Vance said. Vance said if you see more than one doctor, don't assume they're all on the same page, something Lori can relate to. "That's one of the first things we are asked when we go to each one of the doctors, has there been a medication change so that this doctor knows that this doctor made changes," Lori said. Many times seniors need help conveying all of the information. Whether it's a son or daughter, a trusted friend, or even a registered nurse, the experts say seniors should have someone attend appointments with them. Knowledge is power, especially at the doctor's office. If you're in need of financial help with long term care providers, there are non-profit groups that offer assistance. LeadingAge PA is a trade association representing Pennsylvania not-for-profit organizations that provide housing, healthcare and community services primarily to the elderly. To see if you qualify for any of their programs, click here: http://leadingagepa.com/
Просмотров: 380 Local 21 news
Pharmocracy - How Much are Americans Overpaying for Prescription Drugs?
 
02:04
http://lef.org/pharmocracy This eye-opening video exposes the inefficient and corrupt reasons why medical prices have skyrocketed out of control. More important, it provides a blueprint for what citizens can do to combat the regulatory stranglehold over health care that enables the medical establishment to defraud consumers out of their health and money.
Просмотров: 361 Life Extension
Sticker Shock  What is the Antidote for High Cost Drugs
 
58:09
What is fueling the skyrocketing price increases for lifesaving drugs such as Epipen, Daraprim and some specialty drugs? Are there benefit changes to consider when facing prescription drug costs that seem to increase by 100% - 500% overnight? Learn how to take advantage of potential cost savings with the release of an “authorized generic” by a brand drug manufacturer and how to “take the fight” to PBMs on biosimilar rebates. Join Greg Madsen and Michael Staab for an eye-opening one hour webinar and determine what you can do to get prescription drug costs under control.
Government mulls price control of drugs   - The News
 
03:02
The government is pushing the Indian Medical Association for the availability of affordable healthcare by bringing down the price of generic drugs. According to the government, when a patient who is running a fever, consults a doctor, the doctor should prescribe the name of the medicine and not the brand. Link: http://www.mirrornow.in/property/videos/urban-issues/government-mulls-price-control-of-drugs/44164 For More Updates: http://www.mirrornow.in/property
Просмотров: 24 Mirror Now
Linking cancer drug prices to their performance
 
02:46
Should the cost of cancer drugs be tied to how well they work?
Просмотров: 127 NBRbizrpt